0001683168-21-005204.txt : 20211102 0001683168-21-005204.hdr.sgml : 20211102 20211102215142 ACCESSION NUMBER: 0001683168-21-005204 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211029 FILED AS OF DATE: 20211102 DATE AS OF CHANGE: 20211102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MITRANI MARIA INES CENTRAL INDEX KEY: 0001690319 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55008 FILM NUMBER: 211373514 MAIL ADDRESS: STREET 1: 4045 SHERIDAN AVE. STREET 2: SUITE 239 CITY: MIAMI STATE: FL ZIP: 33140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Organicell Regenerative Medicine, Inc. CENTRAL INDEX KEY: 0001557376 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS TRANSPORTATION EQUIPMENT [3790] IRS NUMBER: 474180540 STATE OF INCORPORATION: NV FISCAL YEAR END: 1031 BUSINESS ADDRESS: STREET 1: 4045 SHERIDAN AVENUE STREET 2: SUITE 239 CITY: MIAMI STATE: FL ZIP: 33140 BUSINESS PHONE: 888-963-7881 MAIL ADDRESS: STREET 1: 4045 SHERIDAN AVENUE STREET 2: SUITE 239 CITY: MIAMI STATE: FL ZIP: 33140 FORMER COMPANY: FORMER CONFORMED NAME: Biotech Products Services & Research, Inc. DATE OF NAME CHANGE: 20150917 FORMER COMPANY: FORMER CONFORMED NAME: BESPOKE TRICYCLES INC DATE OF NAME CHANGE: 20120831 4 1 ownership.xml X0306 4 2021-10-29 0 0001557376 Organicell Regenerative Medicine, Inc. BPSR 0001690319 MITRANI MARIA INES 4045 SHERIDAN AVENUE, SUITE 239 MIAMI FL 33140 0 1 0 0 Chief Science Officer Common Stock 2021-10-29 4 J 0 15000000 D 101707890 D Common Stock 2021-10-29 4 J 0 15000000 A 116707890 D Common Stock 166790190 I Additional shares held by spouse The shares of common stock of Organicell Regenerative Medicine, Inc., a Nevada corporation (the "Company") were disposed of and acquired, respectively, pursuant to an Exchange Agreement dated October 29, 2021 (the "Agreement"), whereby the Reporting Person exchanged shares of common stock of the Company previously issued under the Organicell Regenerative Medicine, Inc. Management and Consultants Performance Stock Plan for shares of common stock of the Company in the Organicell Regenerative Medicine, Inc. 2021 Equity Incentive Plan. The newly issued shares shall vest on December 31, 2023. Received in exchange for the Company's common stock on a 1:1 basis. This exchange was completed in connection with the Agreement. The total number of shares of common stock owned collectively by Maria Ines Mitrani and Albert Mitrani is 283,498,080. /s/ Maria Ines Mitrani 2021-11-02